Altre lingue Qlife Holding AB

Azioni

QLIFE

SE0013486552

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 18:00:00 16/07/2024			Variaz. 5gg	Var. 1 gen.
0,0013 ^SEK	+8,33%		+8,33%	-93,47%

02/07	Qlife partecipa a uno studio di ricerca per le persone che vivono con la PKU e ottiene dati positivi	CI
03/06	Qlife inizia la sperimentazione clinica in Cina con il primo biomarcatore su Egoo Health	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Qlife participates research trial for people living with PKU and gets positive data	02/07
Qlife Participates Research Trial for People Living with PKU and Gets Positive Data	02/07
Qlife Holding AB publishes 2023 annual report	05/06
Qlife starts clinical trial in China with first biomarker on Egoo Health	03/06
Qlife Starts Clinical Trial in China with First Biomarker on Egoo Health	03/06
QLIFE HOLDING AB, Interim Report Q1, January to March 2024	28/05
Qlife Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	28/05
Qlife Holding AB enters into an addendum with the holders of the company's convertible debentures and all outstanding convertible debentures are converted into shares	08/05
Qlife Places Danish Operational Company in Reconstruction Mode	05/04
Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure	04/04
Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership	25/03
Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships	25/03
Qlife Signs Letter of Intent with Precision Biosensor	25/03
Qlife is emphasizing that the call today for an extraordinary general meeting (EGM) is a necessity according to Swedish law, but that the company otherwise is following its plans.	21/03
Qlife Secures Core Patent for Egoo System in EU, UK Markets	23/02
Qlife Announces its Core Patent for Egoo System Grants in EU and Other Countries in European Market, as Well as in United Kingdom	23/02
Qlife Holding AB Announces Update on Collaboration with Hipro Biotechnology	16/02
Qlife publishes prospectus due to upcoming rights issue of units	09/02
Qlife Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	09/02
Qlife Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	09/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Qlife Holding AB

Azioni

QLIFE

SE0013486552

Altre lingue

Filtri